在门发育不良症中检测PIK3CA突变
Hillary R Johnson1, Elise C Dietmann2, Corinne E Praska1
1Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin.
The Journal of surgical research
|October 1, 2025
概括
酸氨基 (3,4,5) -三酸激酶 (PI3K) 突变在门发育不良时被发现,并且随着疾病的严重程度而增加. 这些PIK3CA突变可能有助于识别高风险癌进展的患者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 门癌症的发病率正在上升,门发育不良作为其前体.
- 由于缺乏分子生物标志物,预测从发育不良到癌症的进展是具有挑战性的.
- 在癌中,PIK3CA基因经常发生突变.
研究的目的:
- 为了调查癌前门病变中PIK3CA突变的存在.
- 探索PIK3CA突变作为癌风险分层的潜在生物标志物.
主要方法:
- 从甲固定,氨酸嵌入的门组织中提取DNA.
- 数字聚合酶链反应 (dPCR) 来检测常见的PIK3CA突变 (E545 K,H1047 R,H1047 L).
- 突变数据与组织学和人口统计数据的比较.
主要成果:
- 在124个样本中,在52个样本中 (42%) 检测到PIK3CA突变.
- 突变发生率随着疾病程度的增加而增加:19%的低度形,31%的高度形和54%的癌症.
- PIK3CA突变的存在与更高的疾病级别 (P = 0.004) 有显著的关联.
结论:
- 在癌发生的全谱中,可以检测到PIK3CA突变.
- 随着部疾病的程度,PIK3CA突变的发生频率会增加.
- 需要进一步研究PIK3CA突变作为部发育不良进展的生物标志物.
更多相关视频
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
11.4K
06:53Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
9.1K
相关概念视频
03:14Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...